Zydus Cadila files NDA for Saroglitazar Magnesium
NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Cadila
Zydus Cadila gets US FDA nod for Isosorbide Dinitrate tablets, Desonide Cream
The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin…
Zydus Cadila gets EIR from US FDA for Ankleshwar facility
The EIR report stated that the classification of the facility is "No Action Indicated (NAI)", the company added
Zydus Cadila receives DCGI nod to market rabies drug in India
The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for…
Reduce GST, form a separate ministry of pharma, zones for creation of medicines: Indian pharma body…
As per a report prepared by the IPA, at its current rate of seven to eight per cent CAGR, the Indian pharmaceutical industry is…
Zydus Cadila launches insomnia drug in the US market
The drug will be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad
Zydus Cadila to market anti-psychotic drug
The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval
Zydus Cadila receives US FDA approval for blood pressure drug
The drug will be manufactured at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad
Zydus receives US FDA approval for Temozolomide capsules and Nadolol tablets
Both drugs to be manufactured at the company’s formulations manufacturing facility at the Pharma SEZ, Ahmedabad
Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD
ZYAN1 has been shown to improve iron mobilisation and has the potential to reduce or eliminate the need for iron supplementation